Member Briefing: The Supreme Court Decision on Myriad Case

Thursday, June 20 2013
3:00 pm – 4:00 pm

Location: Conference Call

This event will be held as a conference call and the call will be taped. Please register in advance so we can send call-in information to you.

Last week, the U.S. Supreme Court ruled unanimously in Association for Molecular Pathology vs. Myriad Genetics that isolated genomic DNA can not be patented. Join us for a brief call with some initial analysis from some industry experts.

Panelists:

  • Hans Sauer, Associate General Counsel, IP, BIO
  • Gregory D. Williams, Attorney at Law, Pepper Hamilton LLP
  • Konstantin M Linnik, PhD, Partner / Attorney at Law, Nutter McClennen & Fish LLP

 

****This event will be held as a conference call. Questions can be emailed in advance and during the call to Susan Silberman at susan.silberman@massbio.org with the subject line "Supreme Court Call."  

Questions will be reviewed and posed to the panelists at the end of the panel discussion.

Share MassBio

 

BioProcess

EvaluatePharma 

MassBio